Electromed, Inc. reported record quarterly and annual revenues and operating income for fiscal year 2025, showing consistent growth.
Net revenue in Q4 FY 2025 increased by 17.3% to $17.4 million, with operating income reaching a record $3.0 million.
In fiscal year 2025, net revenue grew by 17.0% to $64.0 million, with operating income increasing by 46.8% to $9.7 million.
Revenue Growth
Q4 FY 2025 revenue increased by 17.3% and FY 2025 revenue grew by 17.0%, reflecting strong performance.
Operating Income
Operating income in Q4 FY 2025 reached a record $3.0 million, and FY 2025 saw a significant increase to $9.7 million.
Net Income
Net income for Q4 FY 2025 was $2.2 million, or $0.25 per diluted share, highlighting positive earnings growth.
Sales Expansion
Electromed added to the Russell 2000 and 3000 indexes in June 2025, indicating increased market recognition.
Operational Efficiency
Focused on operational enhancements, including staff expansion, manufacturing optimization, and CRM system implementation for future growth.
- Electromed's strong financial performance in FY 2025 showcases the success of its growth strategies and operational improvements.
- The increase in net revenue and operating income demonstrates the company's ability to capture market share and drive profitability.
- Expansion into the Russell indexes and emphasis on operational efficiency position Electromed for continued growth and market leadership.
In conclusion, Electromed's fiscal 2025 results reflect a remarkable year of growth and profitability, driven by strategic initiatives and operational enhancements.